Home/Filings/4/0000875320-08-000087
4//SEC Filing

GARRISON RICHARD C 4

Accession 0000875320-08-000087

CIK 0000875320other

Filed

Nov 18, 7:00 PM ET

Accepted

Nov 19, 4:24 PM ET

Size

6.0 KB

Accession

0000875320-08-000087

Insider Transaction Report

Form 4
Period: 2008-11-18
GARRISON RICHARD C
SVP and Catalyst
Transactions
  • Sale

    Common Stock

    2008-11-18$26.12/sh86$2,24629,282 total
Holdings
  • Common Stock

    (indirect: By 401(k))
    799
Footnotes (3)
  • [F1]Transaction made pursuant to Mr. Garrison's company approved trading plan established under Rule 10b5-1.
  • [F2]Open market sales reported on this line occurred at a wieghted average price of $26.12 (range $25.70 to $26.53).
  • [F3]Mr. Garrison undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

Issuer

VERTEX PHARMACEUTICALS INC / MA

CIK 0000875320

Entity typeother

Related Parties

1
  • filerCIK 0001256466

Filing Metadata

Form type
4
Filed
Nov 18, 7:00 PM ET
Accepted
Nov 19, 4:24 PM ET
Size
6.0 KB